|premium|

Mid-afternoon market update: Dow surges over 100 points; Provention Bio (PRVB Stock) shares plunge

Toward the end of trading Friday, the Dow traded up 0.42% to 33,645.90 while the NASDAQ rose 0.06% to 13,837.33. The S&P also rose, gaining 0.32% to 4,110.11.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 31,003,070 cases with around 560,110 deaths. Brazil reported over 13,279,850 COVID-19 cases with 345,020 deaths, while India confirmed a total of at least 13,060,540 cases and 167,640 deaths. In total, there were at least 134,038,180 cases of COVID-19 worldwide with more than 2,904,550 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Consumer discretionary shares rose 0.7% on Friday. Meanwhile, top gainers in the sector included China Online Education Group COE 9.78%, up 11%, and Natuzzi S.p.A. NTZ 16.12%, up 15%.

In trading on Friday, consumer staples shares fell 0.6%.

Top Headline

Producer prices for final demand increased 1% in March after a 0.5% rise in January. However, analysts were expecting for a 0.5% rise.

Equities Trading UP

Celcuity Inc. CELC 44.23% shares shot up 46% to $20.88 after the company announced a worldwide licensing agreement with Pfizer to develop and commercialize gedatolisib. Separately, Celcuity reported positive preliminary data for the 103 patients enrolled in the expansion portion of an ongoing Phase 1b clinical trial evaluating gedatolisib, plus Ibrance and endocrine therapy, in ER+/HER2- advanced or metastatic breast cancer patients.

Shares of Affimed N.V. AFMD 23.58% got a boost, shooting 22% to $9.64 after the company announced initial clinical data from an investigator-sponsored study evaluating cord blood-derived natural killer (cbNK) cells pre-complexed with Affimed's innate cell engager (ICE) AFM13 (CD16A/CD30).

fuboTV Inc. FUBO 11.84% shares were also up, gaining 13% to $23.43 after the company announced it acquired exclusive streaming rights to the Qatar World Cup 2022 Qualifying matches of South American Football Confederation.

Check out these big movers of the day

Equities Trading DOWN

Novo Integrated Sciences, Inc. NVOS 24.27% shares tumbled 23% to $2.7450 after the company reported pricing of $8 million registered direct offering at $3.35 per share.

Shares of WD-40 Company WDFC 12.21% were down 15% to $262.92 after the company reported downbeat Q2 results.

Provention Bio, Inc. PRVB 17.93% was down, falling 18% to $8.01 after the company said it has been notified by the FDA that it has identified deficiencies in the company's biologic license application for teplizumab for the delay or prevention of clinical type 1 diabetes. The identified deficiencies preclude discussion of labeling and post-marketing requirements/commitments at this time, the company said, citing the FDA.

Commodities

In commodity news, oil traded down 0.3% to $59.43, while gold traded down 0.7% to $1,745.50.

Silver traded down 1.1% Friday to $25.31 while copper fell 1.3% to $4.0410.

Euro zone

European shares closed mixed today. The eurozone’s STOXX 600 rose 0.08%, the Spanish Ibex Index fell 0.83% and the German DAX 30 gained 0.21%. Meanwhile, the French CAC 40 rose 0.06%, London’s FTSE 100 fell 0.38% and Italy’s FTSE MIB fell 0.60%.

UK’s Halifax house price index increased 6.5% year-over-year in March. Spain's industrial production fell 2.1% from a year ago in February, while industrial production in France dropped 4.7% in February.

German current account surplus shrank to EUR 18.8 billion in February from EUR 20.2 billion in the year-ago month, while trade surplus narrowed to €18.1 billion from €20.3 billion. Industrial production in Germany declined 1.6% in February.

Economics

Producer prices for final demand increased 1% in March after a 0.5% rise in January. However, analysts were expecting for a 0.5% rise.

Wholesale inventories in the US rose 0.6% in February following a 1.4% increase in January.

The total number of active U.S. oil rigs came in unchanged at 337 rigs this week, Baker Hughes Inc reported.

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

GBP/USD loses momentum, flirts with 1.3200

GBP/USD is struggling to maintain its positive bias on Thursday, retreating toward the 1.3200 region in response to the pick in the buying interest around the Greenback. That said, Cable remains under scrutiny as cautious market sentiment keeps investors focused on the US-Iran conflict and political effervescence in the UK.

EUR/USD trims gains, challenges 1.1400

EUR/USD now gives away part of its earlier advance, receding toward the 1.1400 contention zone on Thursday. Meanwhile, the pair’s recovery comes amid extra losses in the US Dollar, at the time when while investors continue to monitor developments in the Middle East and sentiment surrounding global technology stocks.

Gold remains bid and close to $4,100

Gold accelerates its recovery and approaches the key $4,000 mark per troy ounce at the end of the week, adding to Thursday’s advance. However, expectations for a hawkish Fed remain steady and keep the yellow metal’s potential upside contained.

Crypto Today: Bitcoin at $60,000, Ethereum at $1,500, and XRP at $1 face a make-or-break test

Bitcoin (BTC), Ethereum (ETH), and Ripple (XRP) are trading in the red on Friday after three consecutive days of losses, testing their respective make-or-break support levels.

Week ahead – NFP report to challenge Dollar strength and the hawkish Fed

Dollar strength dominates markets, as the hawkish Fed overshadows geopolitics and lower oil prices. NFP week could drive September Fed hike expectations and boost market volatility. The euro lacks fresh bullish catalysts, all eyes on the preliminary inflation report and the ECB Forum.

Regime change: Inside Kevin Warsh's first move to make the Fed unreadable on purpose

The rate did not move. That was the least interesting thing about Kevin Warsh's first meeting in charge of the Fed. The FOMC held its benchmark at 3.50%-3.75% for the fourth straight meeting, exactly as priced, and then the new chair used his first press conference to dismantle the machinery the market has leaned on for a decade.